I agree that this site is using cookies. You can find further informations here.
X
Topalian, Suzanne L
168  results:
Search for persons X
?
1

Comparing anti-tumor and anti-self immunity in a patient wi..:

Chen, Shuming ; McMiller, Tracee L. ; Soni, Abha...
Journal of Translational Medicine.  22 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
2

Circulating cancer-specific CD8 T cell frequency is associa..:

Pulliam, Thomas ; Jani, Saumya ; Jing, Lichen...
Cell Reports Medicine.  5 (2024)  2 - p. 101412 , 2024
Link: https://doi.org/10.1016/..
 
?
3

T antigen–specific CD8+ T cells associate with PD-1 blockad..:

Hansen, Ulla Kring ; Church, Candice D. ; Carnaz Simões, Ana Micaela...
Journal of Clinical Investigation.  134 (2024)  8 - p. , 2024
Link: https://doi.org/10.1172/..
 
?
4

Nivolumab with or without ipilimumab in patients with recur..:

Oaknin, Ana ; Moore, Kathleen ; Meyer, Tim...
The Lancet Oncology.  25 (2024)  5 - p. 588-602 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Combinatorial biomarker for predicting outcomes to anti-PD-..:

Deutsch, Julie Stein ; Lipson, Evan J. ; Danilova, Ludmila...
Cell Reports Medicine.  4 (2023)  2 - p. 100947 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in ..:

Rosner, Samuel ; Reuss, Joshua E. ; Zahurak, Marianna...
Clinical Cancer Research.  29 (2023)  4 - p. 705-710 , 2023
Link: https://doi.org/10.1158/..
 
?
7

Neoadjuvant immune checkpoint blockade: A window of opportu..:

Topalian, Suzanne L. ; Forde, Patrick M. ; Emens, Leisha A....
Cancer Cell.  41 (2023)  9 - p. 1551-1566 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Analysis of multispectral imaging with the AstroPath platfo..:

Berry, Sneha ; Giraldo, Nicolas A. ; Green, Benjamin F....
Science.  372 (2021)  6547 - p. , 2021
Link: https://doi.org/10.1126/..
 
?
9

Neoadjuvant nivolumab for patients with resectable HPV-posi..:

Ferris, Robert L ; Spanos, William C ; Leidner, Rom...
Journal for ImmunoTherapy of Cancer.  9 (2021)  6 - p. e002568 , 2021
Link: https://doi.org/10.1136/..
 
?
10

Three-year survival, correlates and salvage therapies in pa..:

Nghiem, Paul ; Bhatia, Shailender ; Lipson, Evan J...
Journal for ImmunoTherapy of Cancer.  9 (2021)  4 - p. e002478 , 2021
Link: https://doi.org/10.1136/..
 
?
11

Neoadjuvant nivolumab plus ipilimumab in resectable non-sma..:

Reuss, Joshua E ; Anagnostou, Valsamo ; Cottrell, Tricia R...
Journal for ImmunoTherapy of Cancer.  8 (2020)  2 - p. e001282 , 2020
Link: https://doi.org/10.1136/..
 
?
12

Neoadjuvant checkpoint blockade for cancer immunotherapy:

Topalian, Suzanne L. ; Taube, Janis M. ; Pardoll, Drew M.
Science.  367 (2020)  6477 - p. , 2020
Link: https://doi.org/10.1126/..
 
?
13

Integrative Tumor and Immune Cell Multi-omic Analyses Predi..:

Anagnostou, Valsamo ; Bruhm, Daniel C. ; Niknafs, Noushin...
Cell Reports Medicine.  1 (2020)  8 - p. 100139 , 2020
Link: https://doi.org/10.1016/..
 
?
14

Defining tumor resistance to PD-1 pathway blockade: recomme..:

Kluger, Harriet M. ; Tawbi, Hussein A. ; Ascierto, Maria L....
Journal for ImmunoTherapy of Cancer.  8 (2020)  1 - p. e000398 , 2020
Link: https://doi.org/10.1136/..
 
?
15

Characterization of the tumor immune microenvironment in hu..:

Succaria, Farah ; Kvistborg, Pia ; Stein, Julie E....
Cancer Immunology, Immunotherapy.  70 (2020)  5 - p. 1227-1237 , 2020
Link: https://doi.org/10.1007/..
 
1-15